Septic shock, a severe and often fatal condition, is triggered by microbial invasion and significantly exacerbated by the substances these microbes release, initiating inflammation and tissue damage. This condition represents the most severe end of the sepsis severity spectrum, with mortality rates soaring to approximately 40% for sepsis and near 90% for septic shock. Predominantly caused by gram-negative bacteria such as Klebsiella, Pseudomonas, E. coli, or Proteus, septic shock can also result from gram-positive cocci infections, with a notable percentage originating from urinary tract infections.
The infection leads to the release of endotoxins, causing vasodilation and a cascade of effects including hypotension and cardio-depression. Despite having adequate blood volume, the extreme vasodilation results in blood pooling. The initial, or "warm," stage of septic shock is characterized by symptoms like high cardiac output and good blood pressure, but without prompt recognition and early resuscitation, including fluids and antibiotics, the outlook worsens.
As the condition progresses to the "cold" stage, widespread vasodilation causes blood to stagnate, leading to arrhythmias, decreased cardiac output, acidosis, and tissue ischemia. Treatment strategies emphasize fluid resuscitation, with vasopressors like norepinephrine recommended as the first-line agent to improve blood pressure without causing arrhythmias. Vasopressin and, if necessary, epinephrine can be added, while the indiscriminate use of drugs like phenylephrine, dobutamine, and dopamine is discouraged due to potential adverse effects. Additionally, corticosteroids help regulate vascular sensitivity, and emerging treatments such as methylene blue, thiamine, and ascorbic acid offer potential support in managing this critical condition.
